Skip to main content
ProGigFinderBusiness

Every requirement in this grant, in one checklist

Eligibility rules first, then what the application must contain. One row per requirement, each quoting the funder's own words, with columns for who owns it. Opens in Excel.

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health · Deadline 20 November 2026

Free for published grants. No account needed.

What this is

A working checklist built from the published funding notice. Every line is quoted from the source so you can verify it. It is not legal or grant-writing advice, and it does not replace reading the full notice, including any amendments the funder posts later.